Home
Tools
Resources
Blog
About

Search

Medicines Law & Policy Research and resources on intellectual property and health

Home
Tools
Resources
Blog
About

Tag: European Commission

European Commission Publishes Expert Panel’s Recommendations on High Drug Prices

Ellen 't Hoen - February 20, 2018

Recent Posts

Dutch health insurance company Menzis takes AstraZeneca to court over patent evergreening
CJEU Ruling on Truvada recalls ‘evergreening’ goes against public health interests
New Dutch Foundation to Address High Medicines Pricing Announces Plan to File Complaint with Competition Authority
Opmerkingen bij de notitie Dwanglicenties van B.J. Bruins, Minister voor Medische Zorg.

Posts by Subject

Access to Medicines Cancer CDCA competition law Compulsory licensing compulsory licensing for export CRISPR Data exclusivity Delinkage dolutegravir EMA European Commission European Court European Union evergreening France Gilead Hepatitis C HIV India innovation Italy LDCs market exclusivity Medicines Patent Pool Medicines Pricing Netherlands Orphan Drugs Patents PrEP R&D rare diseases Scotland Seroquel Sofosbuvir Spain SPC Supplementary Protection Certificates TRIPS flexibilities Truvada United Kingdom United Nations High Level Panel WHO WIPO WTO

Medicines Law & Policy releases analysis, policy recommendations and tools to aid practitioners working on universal access to medicines. We strive to provide information that is as accurate as possible, and we welcome and encourage feedback. For comments or questions contact us at: info@medicineslawandpolicy.net.

This work is licensed under Creative Commons.